• Insights Into the Oncology Landscape in China Neeta Ratanghayra
    December 24, 2020
    Significant increases in incidence rates have made cancer a high priority in China. Despite major government reforms to reduce cancer burdens, problems remain. To fulfill its agenda in cancer innovation, China is embracing new frontiers and opportunities.
PharmaSources Customer Service